If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
NEW YORK–(HSMN NewsFeed)–Forest Laboratories (NYSE:FRX ) announced today its agreement to acquire additional rights to NXL 104, which amends the terms of its prior agreement with Novexel covering the combination of NXL 104 with ceftaroline and adds addit…
Biopharmaceuticals, Licensing
Forest Laboratories, NXL 104, Beta-Lactamase Inhibitor, antibiotic
Posts from ‘December, 2009’
Forest Laboratories Announces Acquisition of Additional Rights Related to NXL 104, a Novel Broad-Spectrum Beta-Lactamase Inhibitor
SRI Surgical Announces Promotion of Mark Faris to Chief Financial Officer
TAMPA, Fla., Dec. 23, 2009 –(HSMN NewsFeed) — SRI/Surgical Express, Inc. (Nasdaq:STRC ), a leading provider of reusable surgical device reprocessing services supporting the healthcare industry, announces the promotion of Mark R. Faris as Vice President a…
Devices, Surgery, Personnel
Surgical Express, device reprocessing
Volcano Corporation Commends the Elevation of FFR to Level of Evidence A in New PCI Guidelines
Volcano expects these guidelines to broaden usage of FFR in the U.S. SAN DIEGO, Dec. 22 (HSMN NewsFeed) — Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacturing and sales of products for the diagnosis and treatment of coronary…
Devices, Interventional Cardiology
Volcano, Fractional Flow Reserve
University of Pittsburgh Pathology Center (UPMC) Treats Ten,000th Patient with Leksell Gamma Knife Radiosurgery System
Milestone case is 81-year-old male with a deep brain metastasis, an increasingly important indication for minimally invasive technique that uses highly focused radiation beams PITTSBURGH, Dec. 22 (HSMN NewsFeed) — On the morning of December 17, 2009,…
Devices, Oncology, Neurosurgery
Elekta, Gamma Knife, radiosurgery, radiotherapy
Applied NeuroSolutions Announces Increased Scope of Alzheimer’s Disease Drug Discovery Collaboration With Eli Lilly and Company
VERNON HILLS, IL - (HSMN NewsFeed) - Applied NeuroSolutions, Inc. (OTC.BB:APSN ) (www.AppliedNeuroSolutions.com), a biotechnology company focused on the development of products for the early diagnosis and treatment of Alzheimer’s disease ("AD"), …
Biopharmaceuticals, Diagnostics, Neurology
Applied NeuroSolutions, Eli Lilly, Alzheimer’s disease
The Medicines Company Acquires ApoA-I Milano From Pfizer
Product Has Potential to Reverse Plaque Buildup in Arteries PARSIPPANY, NJ and NEW YORK, NY–(HSMN NewsFeed) - The Medicines Company (NASDAQ:MDCO ) today announced the exclusive worldwide licensing of ApoA-I Milano from Pfizer Inc. (NYSE:PFE ). ApoA-I M…
Biopharmaceuticals, Licening
The Medicines Company, Pfizer, ApoA-I Milano
Shire Submits Biologics License Application (BLA) for REPLAGAL(R) With the U.S. Food and Drug Administration (FDA)
Filing Underscores Shire’s Ongoing Commitment to Providing U.S. Fabry Patients With an Alternative Treatment Option. Company Recaps velaglucerase alfa Status CAMBRIDGE, Massachusetts, December 22 (HSMN NewsFeed) — Shire plc (LSE: SHP, NASDAQ: SHPGY),…
Biopharmaceuticals
Shire Plc, REPLAGAL, agalsidase alfa, Fabry disease
Mylan Receives Tentative FDA Approval Under PEPFAR for Matrix Laboratories’ New Drug Application (NDA) for Efavirenz Tablets
PITTSBURGH, Dec. 22 (HSMN NewsFeed) — Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Matrix Laboratories Limited has received tentative approval from the U.S. Food and Drug Administration (FDA) under the President’s Emergency Plan for AIDS…
Biopharmaceuticals, HIV/AIDS
Mylan, Matrix Laboratories, Efavirenz
Dr. Julie Gerberding Named President of Merck Vaccines
WHITEHOUSE STATION, N.J.–(HSMN NewsFeed)–Merck & Co., Inc. (NYSE: MRK ) today announced that Dr. Julie Gerberding has been named president of Merck Vaccines, effective January 25, 2010. Dr. Gerberding led the Centers for Disease Control and Prevention…
Biopharmaceuticals, Personnel
Merck
Gore Expands Line of GORE PROPATEN(R) Vascular Grafts
Integrated radial support offers all the benefits of a ringed graft, while the GORE PROPATEN Bioactive Surface helps to improve thromboresistance and patency FLAGSTAFF, Ariz.–(HSMN NewsFeed)–W. L. Gore & Associates (Gore) today announced it will expan…
Devices, Interventional
W. L. Gore, GORE PROPATEN, Vascular Graft
